Health
AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021 – StreetInsider.com
NORTH CHICAGO, Ill., Nov. 1, 2021 /PRNewswire/ –Â AbbVie (NYSE: ABBV) today announced the presentation of new data on…
NORTH CHICAGO, Ill., Nov. 1, 2021 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced the presentation of new data on RINVOQ® (upadacitinib), SKYRIZI® (risankizumab) and HUMIRA® (adalimumab) across multiple rheumatic diseases at the American College…
Continue Reading
-
Business21 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News20 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General15 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News17 hours agoTips to improve engagement – Proctor